ARWR Arrowhead Pharmaceuticals | $85.60
| 7/27/2026 | | Boost Price Target | $100.00 ➝ $115.00 | Buy | 00.00% | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/27/2026 |
LQDA Liquidia | $86.22
| 7/24/2026 | | Set Price Target | $36.00 | | 00.00% | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 7/24/2026 |
NVCR NovoCure | $17.65
| 7/24/2026 | | Set Price Target | $32.00 | | 00.00% | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 7/24/2026 |
ITGR Integer | $98.61
0.0% | 7/24/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Integer (NYSE:ITGR) on 7/24/2026 |
PRTA Prothena | $8.75
| 7/24/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 7/24/2026 |
LBRX LB Pharmaceuticals | $35.01
| 7/24/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 7/24/2026 |
TEM Tempus AI | $42.69
| 7/24/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 7/24/2026 |
IMAX IMAX | $43.21
-0.4% | 7/24/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of IMAX (NYSE:IMAX) on 7/24/2026 |
LQDA Liquidia | $86.22
| 7/23/2026 | | Boost Price Target | $75.00 ➝ $130.00 | Buy | 00.00% | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 7/23/2026 |
MNKD MannKind | $4.13
| 7/23/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of MannKind (NASDAQ:MNKD) on 7/23/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
IONS Ionis Pharmaceuticals | $56.55
| 7/23/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 7/23/2026 |
BLFS BioLife Solutions | $29.98
| 7/23/2026 | | Downgrade | $32.00 ➝ $31.00 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of BioLife Solutions (NASDAQ:BLFS) on 7/23/2026 |
NVCR NovoCure | $17.65
| 7/23/2026 | | Boost Price Target | $46.00 ➝ $52.00 | Buy | 00.00% | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 7/23/2026 |
SMMT Summit Therapeutics | $13.66
| 7/23/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 7/23/2026 |
ASM Avino Silver & Gold Mines | $5.63
| 7/22/2026 | | Lower Price Target | $13.00 ➝ $10.25 | Buy | 00.00% | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 7/22/2026 |
PVLA Palvella Therapeutics | $138.01
| 7/22/2026 | | Reiterated Rating | $270.00 | Buy | 00.00% | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 7/22/2026 |
BLTE Belite Bio | $153.36
| 7/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 7/22/2026 |
IREN IREN | $37.07
| 7/22/2026 | | Boost Price Target | $85.00 ➝ $90.00 | Buy | 00.00% | View details for HC Wainwright rating of IREN (NASDAQ:IREN) on 7/22/2026 |
DRTS Alpha Tau Medical | $12.50
| 7/22/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 7/22/2026 |
MNPR Monopar Therapeutics | $109.87
| 7/22/2026 | | Boost Price Target | $105.00 ➝ $125.00 | Buy | 00.00% | View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 7/22/2026 |
AGIO Agios Pharmaceuticals | $36.36
| 7/21/2026 | | Lower Price Target | $54.00 ➝ $52.00 | Buy | 00.00% | View details for HC Wainwright rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 7/21/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $28.82
| 7/21/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 7/21/2026 |
GLSI Greenwich LifeSciences | $12.98
| 7/21/2026 | | Boost Price Target | $50.00 ➝ $69.00 | Buy | 00.00% | View details for HC Wainwright rating of Greenwich LifeSciences (NASDAQ:GLSI) on 7/21/2026 |
HALO Halozyme Therapeutics | $81.93
| 7/21/2026 | | Reiterated Rating | $95.00 | Buy | 00.00% | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 7/21/2026 |
INCY Incyte | $117.67
| 7/21/2026 | | Reiterated Rating | $140.00 | Buy | 00.00% | View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 7/21/2026 |
PYPD PolyPid | $3.90
| 7/21/2026 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 7/21/2026 |
OKUR OnKure Therapeutics | $4.12
| 7/20/2026 | | Lower Price Target | $21.00 | Buy | 00.00% | View details for HC Wainwright rating of OnKure Therapeutics (NASDAQ:OKUR) on 7/20/2026 |
HYFT MindWalk | $1.36
| 7/20/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of MindWalk (NASDAQ:HYFT) on 7/20/2026 |
VYGR Voyager Therapeutics | $3.10
| 7/20/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 7/20/2026 |
ANNX Annexon | $5.22
| 7/20/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 7/20/2026 |
INSM Insmed | $106.92
| 7/20/2026 | | Reiterated Rating | $220.00 | Buy | 00.00% | View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 7/20/2026 |
FRHC Freedom | $151.02
| 7/20/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Freedom (NASDAQ:FRHC) on 7/20/2026 |
AARD Aardvark Therapeutics | $6.32
| 7/20/2026 | | Reiterated Rating | $6.00 | Neutral | 00.00% | View details for HC Wainwright rating of Aardvark Therapeutics (NASDAQ:AARD) on 7/20/2026 |
ATAI Atai Beckley | $7.18
| 7/20/2026 | | Downgrade | $25.00 ➝ $7.50 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Atai Beckley (NASDAQ:ATAI) on 7/20/2026 |
FDMT 4D Molecular Therapeutics | $10.07
| 7/20/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/20/2026 |
MLTX MoonLake Immunotherapeutics | $19.02
| 7/20/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 7/20/2026 |
RCUS Arcus Biosciences | $28.41
0.0% | 7/20/2026 | | Boost Price Target | $32.00 ➝ $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Arcus Biosciences (NYSE:RCUS) on 7/20/2026 |
SLGL Sol-Gel Technologies | $81.96
| 7/20/2026 | | Reiterated Rating | $110.00 | Buy | 00.00% | View details for HC Wainwright rating of Sol-Gel Technologies (NASDAQ:SLGL) on 7/20/2026 |
SLNH Soluna | $1.26
| 7/20/2026 | | Initiated Coverage | $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Soluna (NASDAQ:SLNH) on 7/20/2026 |
SOPH SOPHiA GENETICS | $5.72
| 7/20/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for HC Wainwright rating of SOPHiA GENETICS (NASDAQ:SOPH) on 7/20/2026 |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
TRVI Trevi Therapeutics | $17.53
-0.1% | 7/20/2026 | | Boost Price Target | $21.00 ➝ $24.00 | Buy | 00.00% | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 7/20/2026 |
BWAY Brainsway | $15.97
| 7/17/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 7/17/2026 |
GLDG GoldMining | $0.83
| 7/17/2026 | | Lower Price Target | $3.75 ➝ $2.75 | Buy | 00.00% | View details for HC Wainwright rating of GoldMining (NYSEAMERICAN:GLDG) on 7/17/2026 |
CBIO Crescent Biopharma | $16.30
| 7/16/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Crescent Biopharma (NASDAQ:CBIO) on 7/16/2026 |
LEGN Legend Biotech | $22.22
| 7/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 7/16/2026 |
DRD DRDGOLD | $20.98
+0.2% | 7/16/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 7/16/2026 |
DC Dakota Gold | $4.65
| 7/16/2026 | | Boost Price Target | $10.50 ➝ $10.75 | Buy | 00.00% | View details for HC Wainwright rating of Dakota Gold (NYSE:DC) on 7/16/2026 |
DRTS Alpha Tau Medical | $12.50
| 7/16/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 7/16/2026 |
HRMY Harmony Biosciences | $35.32
| 7/16/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 7/16/2026 |
UROY Uranium Royalty | $2.96
| 7/16/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 7/16/2026 |
NB NioCorp Developments | $4.14
| 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of NioCorp Developments (NASDAQ:NB) on 7/15/2026 |
NXTC NextCure | $4.24
| 7/15/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 7/15/2026 |
PMN Promis Neurosciences | $12.20
| 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Promis Neurosciences (NASDAQ:PMN) on 7/15/2026 |
PRLD Prelude Therapeutics | $3.83
| 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 7/15/2026 |
SMMT Summit Therapeutics | $13.66
| 7/15/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 7/15/2026 |
SPTX Seaport Therapeutics | $21.10
| 7/15/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 7/15/2026 |
CELC Celcuity | $82.62
| 7/15/2026 | | Boost Price Target | $145.00 ➝ $155.00 | Buy | 00.00% | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 7/15/2026 |
EVO Evotec | $1.94
| 7/15/2026 | | Lower Price Target | $7.00 ➝ $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 7/15/2026 |
UMAC Unusual Machines | $19.36
| 7/15/2026 | | Initiated Coverage | $42.00 | Buy | 00.00% | View details for HC Wainwright rating of Unusual Machines (NYSEAMERICAN:UMAC) on 7/15/2026 |
ANGO AngioDynamics | $13.59
| 7/15/2026 | | Boost Price Target | $16.00 ➝ $19.00 | Buy | 00.00% | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 7/15/2026 |
AXSM Axsome Therapeutics | $241.00
| 7/15/2026 | | Reiterated Rating | $290.00 | Buy | 00.00% | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 7/15/2026 |
COCH Envoy Medical | $0.66
| 7/15/2026 | | Reiterated Rating | $2.50 | Buy | 00.00% | View details for HC Wainwright rating of Envoy Medical (NASDAQ:COCH) on 7/15/2026 |
CRVO CervoMed | $2.66
| 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 7/15/2026 |
SNDX Syndax Pharmaceuticals | $20.81
| 7/15/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 7/15/2026 |
SPTX Seaport Therapeutics | $21.10
| 7/15/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 7/15/2026 |
UMAC Unusual Machines | $19.36
| 7/15/2026 | | Initiated Coverage | $42.00 | Buy | 00.00% | View details for HC Wainwright rating of Unusual Machines (NYSEAMERICAN:UMAC) on 7/15/2026 |
CLSK Cleanspark | $14.52
| 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Cleanspark (NASDAQ:CLSK) on 7/14/2026 |
ONCY Oncolytics Biotech | $0.81
| 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 7/14/2026 |
ERAS Erasca | $19.11
| 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 7/14/2026 |
MBOT Microbot Medical | $1.71
| 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 7/14/2026 |
BMRN BioMarin Pharmaceutical | $59.33
| 7/14/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 7/14/2026 |
INCY Incyte | $117.67
| 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 7/14/2026 |
CRDL Cardiol Therapeutics | $1.18
| 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 7/14/2026 |
LCTX Lineage Cell Therapeutics | $1.03
| 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 7/14/2026 |
AGEN Agenus | $5.98
| 7/13/2026 | | Boost Price Target | $23.00 ➝ $30.00 | Buy | 00.00% | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 7/13/2026 |
ALNY Alnylam Pharmaceuticals | $271.77
| 7/13/2026 | | Boost Price Target | $470.00 ➝ $485.00 | Buy | 00.00% | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/13/2026 |
APYX Apyx Medical | $3.92
| 7/13/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Apyx Medical (NASDAQ:APYX) on 7/13/2026 |
BBIO BridgeBio Pharma | $84.02
| 7/13/2026 | | Boost Price Target | $110.00 ➝ $120.00 | Buy | 00.00% | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 7/13/2026 |
COAG Hemab Therapeutics | $47.31
| 7/13/2026 | | Boost Price Target | $40.00 ➝ $52.00 | Buy | 00.00% | View details for HC Wainwright rating of Hemab Therapeutics (NASDAQ:COAG) on 7/13/2026 |
OKYO OKYO Pharma | $1.55
| 7/13/2026 | | Lower Price Target | $7.00 ➝ $5.00 | Buy | 00.00% | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 7/13/2026 |
TGTX TG Therapeutics | $56.04
| 7/13/2026 | | Boost Price Target | $70.00 ➝ $77.00 | Buy | 00.00% | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 7/13/2026 |
TRAX First Tracks Biotherapeutics | $35.52
| 7/10/2026 | | Boost Price Target | $30.00 ➝ $44.00 | Buy | 00.00% | View details for HC Wainwright rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 7/10/2026 |
NRIX Nurix Therapeutics | $23.38
| 7/10/2026 | | Boost Price Target | $32.00 ➝ $34.00 | Buy | 00.00% | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 7/10/2026 |
AG First Majestic Silver | $16.31
0.0% | 7/10/2026 | | Lower Price Target | $30.75 ➝ $26.00 | Buy | 00.00% | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 7/10/2026 |
IONS Ionis Pharmaceuticals | $56.55
| 7/10/2026 | | Lower Price Target | $130.00 ➝ $125.00 | Buy | 00.00% | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 7/10/2026 |
URGN Urogen Pharma | $40.97
| 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 7/9/2026 |
IMNM Immunome | $22.21
| 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 7/9/2026 |
RMTI Rockwell Medical | $6.63
| 7/9/2026 | | Reiterated Rating | $2.00 ➝ $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 7/9/2026 |
CRVO CervoMed | $2.66
| 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 7/9/2026 |
DTIL Precision BioSciences | $7.29
| 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 7/9/2026 |
Porter flew 3,300 miles to investigate this system (Ad) Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film.
Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. Watch the full investigation and decide for yourself |
ELVN Enliven Therapeutics | $52.95
| 7/9/2026 | | Boost Price Target | $56.00 ➝ $64.00 | Buy | 00.00% | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 7/9/2026 |
EXK Endeavour Silver | $7.81
-0.2% | 7/9/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 7/9/2026 |
MSLE Satellos Bioscience | $9.78
| 7/9/2026 | | Boost Price Target | $11.00 ➝ $18.00 | Buy | 00.00% | View details for HC Wainwright rating of Satellos Bioscience (NASDAQ:MSLE) on 7/9/2026 |
NKLR Terra Innovatum Global S.R.L. | $5.05
| 7/9/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Terra Innovatum Global S.R.L. (NASDAQ:NKLR) on 7/9/2026 |
PLYX Polaryx Therapeutics | $2.05
| 7/9/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Polaryx Therapeutics (NASDAQ:PLYX) on 7/9/2026 |
TARS Tarsus Pharmaceuticals | $58.66
| 7/9/2026 | | Reiterated Rating | $88.00 | Buy | 00.00% | View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 7/9/2026 |
AXSM Axsome Therapeutics | $241.00
| 7/8/2026 | | Reiterated Rating | $290.00 | Buy | 00.00% | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 7/8/2026 |
CMPS Compass Pathways | $11.26
| 7/8/2026 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for HC Wainwright rating of Compass Pathways (NASDAQ:CMPS) on 7/8/2026 |
CRSP CRISPR Therapeutics | $46.54
| 7/8/2026 | | Reiterated Rating | $80.00 | Buy | 00.00% | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 7/8/2026 |
MGTX MeiraGTx | $11.77
| 7/8/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of MeiraGTx (NASDAQ:MGTX) on 7/8/2026 |
